• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于全国人口的银屑病患者特定病因死亡率研究。

Nationwide population-based study of cause-specific death rates in patients with psoriasis.

作者信息

Salahadeen E, Torp-Pedersen C, Gislason G, Hansen P R, Ahlehoff O

机构信息

Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark.

出版信息

J Eur Acad Dermatol Venereol. 2015 May;29(5):1002-5. doi: 10.1111/jdv.12523. Epub 2014 Jun 9.

DOI:10.1111/jdv.12523
PMID:24909271
Abstract

BACKGROUND

Psoriasis is a common chronic disease, mediated by type 1 and 17 helper T cell-driven inflammation. Epidemiological studies have demonstrated a wide range of comorbidities and increased mortality rates. However, the current evidence on psoriasis-related mortality is limited and nationwide data have not been presented previously.

METHODS

In a nationwide population-based cohort we evaluated all-cause and cause-specific death rates in patients with psoriasis as compared to the general population.

RESULTS

The entire Danish population aged 18 and above, corresponding to a total of 5,458,627 individuals (50.7% female, 40.9 years ± 19.7), including 94,069 with mild psoriasis (53% female, 42.0 ± 17.0 years) and 28,253 with severe psoriasis (53.4% female, 43.0 ± 16.5 years), was included. A total of 884,661 deaths were recorded, including 10 916 in patients with mild psoriasis and 3699 in patients with severe psoriasis. The age at time of death varied by psoriasis status, i.e. 76.5 ± 14.0, 74.4 ± 12.8 and 72.0 ± 13.4 years, for the general population, mild psoriasis and severe psoriasis respectively. In general, the highest death rates were observed in patients with severe psoriasis. Overall death rates per 1000 patient years were 13.8 [confidence interval (CI) 13.8-13.8], 17.0 (CI 16.7-17.3) and 25.4 (CI 24.6-26.3) for the general population, patients with mild psoriasis and patients with severe psoriasis respectively.

CONCLUSION

This nationwide population-based study of cause-specific death rates in patients with psoriasis demonstrated reduced lifespan and increased rates of all examined specific causes of death in patients with psoriasis compared to the general population.

摘要

背景

银屑病是一种常见的慢性疾病,由1型和17型辅助性T细胞驱动炎症介导。流行病学研究已证实其存在广泛的合并症及死亡率增加的情况。然而,目前关于银屑病相关死亡率的证据有限,且此前尚未有全国性数据公布。

方法

在一项基于全国人群的队列研究中,我们评估了银屑病患者与普通人群相比的全因死亡率和特定病因死亡率。

结果

纳入了丹麦所有18岁及以上的人群,共计5,458,627人(女性占50.7%,年龄40.9岁±19.7岁),其中包括94,069例轻度银屑病患者(女性占53%,年龄42.0±17.0岁)和28,253例重度银屑病患者(女性占53.4%,年龄43.0±16.5岁)。共记录了884,661例死亡病例,其中轻度银屑病患者中有10916例死亡,重度银屑病患者中有3699例死亡。死亡时的年龄因银屑病病情而异,普通人群、轻度银屑病患者和重度银屑病患者分别为76.5±14.0岁、74.4±12.8岁和72.0±13.4岁。总体而言,重度银屑病患者的死亡率最高。普通人群、轻度银屑病患者和重度银屑病患者每1000患者年的总体死亡率分别为13.8[置信区间(CI)13.8 - 13.8]、17.0(CI 16.7 - 17.3)和25.4(CI 24.6 - 26.3)。

结论

这项基于全国人群的银屑病患者特定病因死亡率研究表明,与普通人群相比,银屑病患者的寿命缩短,所有检查的特定死因死亡率增加。

相似文献

1
Nationwide population-based study of cause-specific death rates in patients with psoriasis.基于全国人口的银屑病患者特定病因死亡率研究。
J Eur Acad Dermatol Venereol. 2015 May;29(5):1002-5. doi: 10.1111/jdv.12523. Epub 2014 Jun 9.
2
Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study.轻度和重度银屑病患者特定病因死亡率增加:一项基于瑞典人群登记的研究
Acta Derm Venereol. 2015 Sep;95(7):809-15. doi: 10.2340/00015555-2095.
3
Increased risk of aortic valve stenosis in patients with psoriasis: a nationwide cohort study.银屑病患者主动脉瓣狭窄风险增加:一项全国性队列研究。
Eur Heart J. 2015 Aug 21;36(32):2177-83. doi: 10.1093/eurheartj/ehv185. Epub 2015 Jun 8.
4
Psoriasis and risk of heart failure: a nationwide cohort study.银屑病与心力衰竭风险:一项全国性队列研究。
Eur J Heart Fail. 2014 Jul;16(7):743-8. doi: 10.1002/ejhf.113. Epub 2014 Jun 5.
5
Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk.重度银屑病与非心血管死亡率增加相关,但与心血管风险增加无关。
J Invest Dermatol. 2011 May;131(5):1159-66. doi: 10.1038/jid.2010.399. Epub 2011 Jan 20.
6
All-Cause and Cause-Specific Mortality in Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study.台湾银屑病患者的全因死亡率和特定病因死亡率:一项基于全国人口的研究。
J Invest Dermatol. 2017 Jul;137(7):1468-1473. doi: 10.1016/j.jid.2017.01.036. Epub 2017 Feb 28.
7
The risk of mortality in patients with psoriasis: results from a population-based study.银屑病患者的死亡风险:一项基于人群的研究结果。
Arch Dermatol. 2007 Dec;143(12):1493-9. doi: 10.1001/archderm.143.12.1493.
8
Nationwide Study on the Risk of Abdominal Aortic Aneurysms in Patients With Psoriasis.银屑病患者腹主动脉瘤风险的全国性研究。
Arterioscler Thromb Vasc Biol. 2016 May;36(5):1043-8. doi: 10.1161/ATVBAHA.116.307449. Epub 2016 Apr 14.
9
Increased risk of migraine in patients with psoriasis: A Danish nationwide cohort study.银屑病患者偏头痛风险增加:一项丹麦全国队列研究。
J Am Acad Dermatol. 2015 Nov;73(5):829-35. doi: 10.1016/j.jaad.2015.08.039. Epub 2015 Sep 19.
10
Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study.患有严重银屑病的患者使用全身性抗炎药物治疗后的心血管疾病事件发生率:一项丹麦真实世界队列研究。
J Intern Med. 2013 Feb;273(2):197-204. doi: 10.1111/j.1365-2796.2012.02593.x. Epub 2012 Oct 11.

引用本文的文献

1
Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality Rates.波兰银屑病的流行病学:患病率、发病率和死亡率
Int J Dermatol. 2025 Sep;64(9):1599-1606. doi: 10.1111/ijd.17848. Epub 2025 May 19.
2
Influence of psoriasis on infection risk and survival outcomes in patients with head and neck cancer: a retrospective cohort study.银屑病对头颈癌患者感染风险和生存结局的影响:一项回顾性队列研究。
BMC Cancer. 2025 Mar 24;25(1):534. doi: 10.1186/s12885-025-13920-8.
3
Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasis.
与传统抗银屑病药物或阿普米司特不同,生物治疗可降低银屑病患者的死亡风险和心血管疾病风险。
EBioMedicine. 2025 Jan;111:105485. doi: 10.1016/j.ebiom.2024.105485. Epub 2024 Dec 6.
4
Psoriasis and Seasonality: Exploring the Genetic and Epigenetic Interactions.银屑病与季节性:探索遗传与表观遗传的相互作用。
Int J Mol Sci. 2024 Oct 30;25(21):11670. doi: 10.3390/ijms252111670.
5
Chinese Medicine as Supporting Therapy for Psoriasis: Past, Present, and Future.中医作为银屑病的辅助治疗:过去、现在与未来
Chin J Integr Med. 2023 Mar;29(3):280-288. doi: 10.1007/s11655-022-3683-8. Epub 2022 Oct 27.
6
Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study.台湾地区银屑病和银屑病关节炎患者的发病率、患病率和死亡率:一项全国性队列研究。
Acta Derm Venereol. 2022 Nov 1;102:adv00807. doi: 10.2340/actadv.v102.1962.
7
Biomarkers of subclinical atherosclerosis in patients with psoriasis.银屑病患者亚临床动脉粥样硬化的生物标志物。
Sci Rep. 2021 Nov 2;11(1):21438. doi: 10.1038/s41598-021-00999-9.
8
Cardiovascular Risk Associated with Methotrexate versus Retinoids in Patients with Psoriasis: A Nationwide Taiwanese Cohort Study.台湾地区全国性队列研究:甲氨蝶呤与维甲酸类药物治疗银屑病患者的心血管风险比较
Clin Epidemiol. 2021 Aug 11;13:693-705. doi: 10.2147/CLEP.S305126. eCollection 2021.
9
The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis.白细胞介素-23/Th17 通路在与银屑病相关的心血管代谢合并症中的作用。
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1695-1706. doi: 10.1111/jdv.16273. Epub 2020 Mar 15.
10
The Risk of Mortality among Psoriatic Patients with Varying Severity: A Nationwide Population-Based Cohort Study in Taiwan.不同严重程度银屑病患者的死亡风险:台湾一项全国性基于人群的队列研究。
Int J Environ Res Public Health. 2018 Nov 22;15(12):2622. doi: 10.3390/ijerph15122622.